Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 9/20 | 0.61 |
| ▸ | LTB4R2 | Q9NPC1 | 8/20 | 0.61 |
| ▸ | PPARA | Q07869 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.47 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27650897 | 0.85 | PTGS2 (0.60) | PPARAALOX5PTGS2ALDH1A1LMNA | |
| SCHEMBL8686236 | 0.84 | LTB4R (0.59) | LTB4RLTB4R2PPARAHDAC1HDAC6 | |
| SCHEMBL27916839 | 0.84 | PTGS2 (0.68) | PPARAALOX5PTGS2 | |
| SCHEMBL28691569 | 0.83 | PTGS2 (0.59) | LTB4RLTB4R2PPARAALOX5PTGS2 | |
| SCHEMBL1206771 | 0.81 | LTB4R (0.56) | LTB4RLTB4R2PPARALMNAHPGD | |
| Propionic Acid SCHEMBL27928896 | 0.81 | KDM4E (0.53) | LTB4RLTB4R2PPARAALOX5PTGS2 | |
| SCHEMBL6112724 | 0.80 | PPARA (0.52) | LTB4RLTB4R2PPARAALOX5PTGS2 | |
| SCHEMBL7827662 | 0.80 | ALOX5 (0.68) | LTB4RLTB4R2PPARAALOX5PTGS2 | |
| SCHEMBL709396 | 0.80 | LTB4R (0.59) | LTB4RLTB4R2PPARALMNAHPGD | |
| Acetic Acid SCHEMBL27946451 | 0.79 | PPARA (0.54) | PPARAALOX5PTGS2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10807932-B2 | Benzosuberene analogues and related compounds with activity as anticancer agents | BAYLOR UNIVERSITY (US) | 2020-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10807932-B2 | Benzosuberene analogues and related compounds with activity as anticancer agents | TUBB1, TUBB3, TUBB | LTB4R 3130/4885LTB4R2 3403/4885PPARA 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.